BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 10850453)

  • 21. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Biol Chem; 2002 Sep; 277(39):36024-31. PubMed ID: 12130649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
    Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I
    J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells.
    Hayashida T; Schnaper HW
    J Am Soc Nephrol; 2004 Aug; 15(8):2032-41. PubMed ID: 15284289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells.
    Kalina U; Koschmieder S; Hofmann WK; Wagner S; Kauschat D; Hoelzer D; Ottmann OG
    Exp Hematol; 2001 May; 29(5):602-8. PubMed ID: 11376873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    Am J Physiol Renal Physiol; 2003 Sep; 285(3):F413-22. PubMed ID: 12759229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1).
    Pardali K; Kowanetz M; Heldin CH; Moustakas A
    J Cell Physiol; 2005 Jul; 204(1):260-72. PubMed ID: 15690394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
    Hayashida T; Decaestecker M; Schnaper HW
    FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad4 mediates activation of mitogen-activated protein kinases by TGF-beta in pancreatic acinar cells.
    Simeone DM; Zhang L; Graziano K; Nicke B; Pham T; Schaefer C; Logsdon CD
    Am J Physiol Cell Physiol; 2001 Jul; 281(1):C311-9. PubMed ID: 11401854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition.
    Han C; Demetris AJ; Liu Y; Shelhamer JH; Wu T
    J Biol Chem; 2004 Oct; 279(43):44344-54. PubMed ID: 15294900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of p21(WAF1/CIP1) leads to morphologic changes and esterase activity in TPA-mediated differentiation of human prostate cancer cell line TSU-Pr1.
    Sugibayashi R; Shimizu T; Suzuki T; Yamamoto N; Hamada H; Takeda K
    Oncogene; 2001 Mar; 20(10):1220-8. PubMed ID: 11313866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K; Sheng H; Shao J; Beauchamp RD
    Exp Cell Res; 2001 Jun; 266(2):239-49. PubMed ID: 11399052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
    Kim HS; Luo L; Pflugfelder SC; Li DQ
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
    Marone M; Scambia G; Bonanno G; Rutella S; de Ritis D; Guidi F; Leone G; Pierelli L
    Leukemia; 2002 Jan; 16(1):94-105. PubMed ID: 11840268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling.
    Ungefroren H; Lenschow W; Chen WB; Faendrich F; Kalthoff H
    J Biol Chem; 2003 Mar; 278(13):11041-9. PubMed ID: 12538652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of Smad4 results in resistance against the growth-inhibitory effect of transforming growth factor-beta in the SiHa human cervical carcinoma cell line.
    Lee S; Cho YS; Shim C; Kim J; Choi J; Oh S; Kim J; Zhang W; Lee J
    Int J Cancer; 2001 Nov; 94(4):500-7. PubMed ID: 11745435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.